Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous vs Intermittent Vancomycin in Neonates
NCT02210169Completed
- Sponsor
- Murdoch Children's Research Institute
- Start
- Sep 2014
- Primary completion
- Apr 2018
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of vancomycin in sepsis, Infection and Bacteremia, sponsored by Murdoch Children's Research Institute. Primary endpoint: Proportion of neonates achieving target vancomycin concentrations in blood at steady state. Started Sep 2014; status: completed.
02
Drugs
vancomycin
03
Conditions
sepsisInfectionBacteremia
Beyond the preview
Go deeper on NCT02210169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02210169.